AI Article Synopsis
- The review discusses current treatment methods and strategies for managing lower urinary tract symptoms (LUTS) linked to treatments like transurethral resection and intravesical therapy.
- Recent findings highlight that while there's limited research, some oral agents and new therapies show promise in alleviating LUTS associated with intravesical treatments, such as phenazopyridine and beta-3 agonists.
- The review emphasizes the need for more research to validate these treatments and to develop effective strategies for managing LUTS in patients undergoing various intravesical therapy regimens.
Article Abstract
Purpose Of Review: This narrative review aims to report upon the existing treatment evidence and strategies for managing lower urinary tract symptoms (LUTS) during treatment, including transurethral resection and intravesical therapy. This review also attempts to examine novel approaches to mitigate treatment-related lower urinary tract symptoms and improve treatment adherence.
Recent Findings: There is sparse but promising evidence in improving LUTS secondary to intravesical therapy. Oral agents including phenazopyridine and hyaluronic acid, Bacillus Calmette-Guerin dose reduction, and emerging therapies including beta-3 agonists as well as Onabotulinumtoxin A injections all have demonstrated encouraging improvement in LUTS in limited research. Although recent literature explores new medications and potential strategies for managing intravesical therapy-related LUTS, further research is required to establish efficacy and new consensus on treatment strategies. Further research is also required to establish effective LUTS mitigation strategies with other emerging intravesical therapy regimens.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11934-024-01250-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Five-year sustainability of a de-implementation strategy to reduce inappropriate use of catheters: a multicentre, mixed-methods study.
EClinicalMedicine
September 2024
Amsterdam UMC, University of Amsterdam, Department of Internal Medicine-Infectious Diseases, Amsterdam Institute for Infection and Immunity, Amsterdam Public Health, the Netherlands.
Background: The use of peripheral intravenous catheters (PIVCs) contributes to healthcare-associated infections. In 2017, we implemented a multifaceted de-implementation strategy that successfully reduced the inappropriate use of catheters in seven hospitals in the Netherlands (RICAT-1 study). Five years later, we investigated the sustainability of this strategy and the contributing factors.
View Article and Find Full Text PDFEfficacy and Safety of Silodosin for the Treatment of Female LUTS: A 12-Week Prospective, Single-Center Study.
Low Urin Tract Symptoms
January 2025
Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
Objectives: This study aimed to evaluate the clinical efficacy and safety of silodosin in female patients with lower urinary tract symptoms (LUTSs), addressing the limited evidence supporting alpha-blocker use in this population.
Methods: A 12-week, single-arm, prospective, open-label study was conducted from May 2021 to January 2023. Female patients aged over 18 with an International Prostate Symptom Score (IPSS) ≥ 8 were enrolled and treated with silodosin (8 mg once daily).
Effect of Electroacupuncture Treatment on Bladder Function and Urodynamic Features of Neurogenic Bladder in Stroke: A Retrospective Study.
Arch Esp Urol
December 2024
Department of Urology, Jinggangshan University Affiliated Hospital, 343000 Ji'an, Jiangxi, China.
Background: Neurogenic bladder dysfunction is a common consequence of stroke, and it substantially impacts the quality of life and functional independence of affected individuals. Traditional treatment modalities have limitations in achieving optimal outcomes. This study aims to explore the effects of electroacupuncture treatment on bladder function and neurogenic bladder urodynamic characteristics in stroke patients.
View Article and Find Full Text PDFTherapeutic Efficacy of Re-Lin-Qing Granules in Treating Type 2 Diabetes Mellitus Complicated with Urinary Tract Infection: A Retrospective Study.
Arch Esp Urol
December 2024
Department of Traditional Chinese Medicine, The First Affiliated Hospital of Wenzhou Medical University, 325000 Wenzhou, Zhejiang, China.
Purpose: Urinary tract infections (UTIs) frequently occur in patients with type 2 diabetes mellitus (T2DM), presenting a complex pathogenesis that significantly impairs patient quality of life. Despite the availability of various clinical treatments, challenges remain regarding their efficacy and safety. Therefore, this retrospective study aimed to observe the therapeutic effects of Re-Lin-Qing granules in treating T2DM complicated by UTIs, aiming to provide more scientifically validated and effective treatment options for clinical practice.
View Article and Find Full Text PDFIdentifying Risk Factors for Urinary Tract Stones in Pregnant Women at a Tertiary Hospital in China: A Retrospective Survey.
Arch Esp Urol
December 2024
Obstetrics and Gynecology Department, Anhui Wannan Rehabilitation Hospital (The Fifth People's Hospital of Wuhu), 241000 Wuhu, Anhui, China.
Background: Urinary tract stones present significant health risks to pregnant women and their foetuses. However, the specific risk factors contributing to stone formation during pregnancy, particularly within the Chinese population, remain poorly understood. This retrospective survey aimed to identify demographic, clinical, and obstetric risk factors associated with urinary tract stones in pregnant women at a tertiary hospital in China.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!